Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / APM - Aptorum Group: Advancing Oncology Autoimmune & Infectious Disease Therapies


APM - Aptorum Group: Advancing Oncology Autoimmune & Infectious Disease Therapies

  • Aptorum Group is advancing therapeutic programs to serve unmet needs in orphan oncology diseases, infectious diseases, metabolic diseases, women's health and other areas.
  • The company completed Phase 1 clinical trials for its two lead candidates ALS-4 and SACT-1.
  • The company also launched its oncology and autoimmune discovery and development platform focusing initially on NSCLC, Lupus, RA, IBD, etc.

For further details see:

Aptorum Group: Advancing Oncology, Autoimmune & Infectious Disease Therapies
Stock Information

Company Name: Aptorum Group Limited
Stock Symbol: APM
Market: NASDAQ
Website: aptorumgroup.com

Menu

APM APM Quote APM Short APM News APM Articles APM Message Board
Get APM Alerts

News, Short Squeeze, Breakout and More Instantly...